Ministry of Chemical & Fertilizers announces revised Guidelines for Scheme for "Strengthening of Pharmaceuticals Industry (SPI)”

Posted 18 Mar 2024

Updated 28 Mar 2024

2 min read

SPI scheme addresses requirement for support to existing pharma clusters to improve productivity, quality and sustainability to make India a global leader in Pharma Sector.
- SPI Tenure: FY 2021-2022 to FY 2025-26 (5 years).
SPI Scheme has three components
- Assistance to Pharmaceutical Industry for Common Facilities (APICF)
- Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS)
- Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS)

Aim: Strengthen existing pharmaceutical clusters’ capacity for their sustained growth by creating common facilities.
Tenure: 5 years.
Limit of incentive will be 70% of approved project cost or Rs 20 crore, whichever is less,
Eligible activities: R&D Labs; Testing Laboratory for Pharma Products; Effluent Treatment Plants; Logistic Centers; Training Centers.
Monitoring: Project Management Consultant (PMC), agency appointed by Department of Pharmaceuticals (DoP).
Benefits:
- Improvement in quality standards and environmental regulatory compliance;
- Reduction in wastage of manufactured pharma products;
- Increased availability of trained personnel for pharma clusters; etc.

Aim: Facilitate growth and development of Pharmaceutical and Medical Devices Sectors through conducting studies, awareness programs, etc.
Tenure: 5 years.
Eligible activities: Database Creation of pharmaceutical and medical device sector, etc.
Monitoring: PMC.
Benefits: Bring awareness about Government policies and identifying problems/issues faced by industry.

Watch News Today

Need to Login First !